We are live on ! Find out more
FULC icon

Fulcrum Therapeutics

66 hedge funds and large institutions have $260M invested in Fulcrum Therapeutics in 2020 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 25 increasing their positions, 12 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

367% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 3

131% more capital inflows, than outflows

Capital inflows: $35.6M | Capital outflows: $15.4M

108% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 12

20% more funds holding

Funds holding: 55 → 66 (+11)

5.72% more ownership

Funds ownership: 75.02% → 80.74% (+5.7%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
66
Holders Change
+11
Holders Change %
+20%
% of All Funds
1.16%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
14
Increased
25
Reduced
12
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

FULC Hedge Fund Activity: Q4 2020 in Review

66 of the 5,680 institutional investors tracked by Wall St. Rank reported a position in Fulcrum Therapeutics (FULC) for Q4 2020, worth a combined $260M — up 59% from $163M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new FULC positions and 3 closed out — a net gain of 11 holders — while 25 added to existing stakes and 12 trimmed.

The largest buyer was RTW Investments, adding an estimated $10.4M. The largest seller was Boxer Capital, exiting entirely with an estimated $5.6M sold.

  • 66 institutional investors held Fulcrum Therapeutics (FULC) as of Q4 2020, up from 55 in Q3 2020.
  • Funds reported $260M of Fulcrum Therapeutics stock for Q4 2020, up 59% quarter-over-quarter.
  • 14 funds opened new Fulcrum Therapeutics positions in Q4 2020 and 3 closed out, a net change of +11 holders.
  • The largest Fulcrum Therapeutics buyer in Q4 2020 was RTW Investments, an estimated $10.4M added.
  • The largest Fulcrum Therapeutics seller in Q4 2020 was Boxer Capital, an estimated $5.6M sold.

Based on aggregated 13F filings for Q4 2020.